Nevertheless, our experiments in FAAP20-deficient cancer cells show that FAAP20’s ability to support HDR repair pathways leads to its ability to maintain cell growth and proliferation during IR treatment, PARPi, and RAD52i. The gene discussed is FAAP20; the disease is cancer.